Zobrazeno 1 - 10
of 453
pro vyhledávání: '"Hajime FUJIMOTO"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Reports on changes in circulating immune cells induced by immune checkpoint inhibitors (ICIs) and their association with therapeutic responses are limited. This study aimed to analyze the interaction between ICIs and circulating b
Externí odkaz:
https://doaj.org/article/8c454217156f4126a45e4cc310592bd2
Autor:
Ryo Nishiwaki, Ichiro Imoto, Satoko Oka, Taro Yasuma, Hajime Fujimoto, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Tetsu Kobayashi, Hataji Osamu, Kodai Fujibe, Kenichiro Nishikawa, Tetsuya Hamaguchi, Natsuko Sugimasa, Midori Noji, Yoshiyuki Ito, Kenji Takeuchi, Isaac Cann, Yasuhiro Inoue, Toshio Kato, Esteban C. Gabazza
Publikováno v:
Gut Pathogens, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Acute cholangitis is a severe, life-threatening infection of the biliary system that requires early diagnosis and treatment. The Tokyo Guidelines recommend a combination of clinical, laboratory, and imaging findings for diagnosis
Externí odkaz:
https://doaj.org/article/1eec259f1b6e43cb9feb9be87973cd65
Autor:
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, Tomohito Okano, Taro Yasuma, Esteban C. Gabazza, Hidenori Ibata, Tetsu Kobayashi
Publikováno v:
Diagnostics, Vol 14, Iss 19, p 2159 (2024)
A 54-year-old female patient diagnosed with Stage IIIb squamous cell carcinoma (cT2aN3M0) initially received chemoradiotherapy. Two years after initial treatment, cancer relapse led to the administration of nivolumab, which was halted due to the deve
Externí odkaz:
https://doaj.org/article/50f3b8b3c3794b17af3bee3b4ffd7ed2
Autor:
Suphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Atsushi Tomaru, Haruko Saiki, Mei Uemura, Yurie Kogue, Toshiyuki Ito, Kazuki Furuhashi, Tomohito Okano, Atsuro Takeshita, Kota Nishihama, Ryoichi Ono, Osamu Hataji, Tetsuya Nosaka, Tetsu Kobayashi, Esteban C. Gabazza
Publikováno v:
Cells, Vol 13, Iss 18, p 1523 (2024)
Idiopathic pulmonary fibrosis (IPF) is a progressive, often fatal lung disease characterized by tissue scarring and declining lung function. The MUC5B promoter polymorphism rs35705950, a significant genetic predisposition for IPF, paradoxically assoc
Externí odkaz:
https://doaj.org/article/a7b349c579fe42088391e7abf4def2b0
Autor:
Yoichi Nishii, Tadashi Sakaguchi, Seiya Esumi, Maki Esumi, Yuki Nakamura, Yuta Suzuki, Kentaro Ito, Kentaro Fujiwara, Hiroki Yasui, Atsushi Ito, Tomohito Tarukawa, Tatsuki Tsuruga, Corina N. D’Alessandro-Gabazza, Taro Yasuma, Hajime Fujimoto, Fumihiro Asano, Esteban C. Gabazza, Tetsu Kobayashi, Osamu Taguchi, Osamu Hataji
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Bronchoscopy with radial-probe endobronchial ultrasound, a guide sheath, and electromagnetic navigation can improve the diagnostic yield of peripheral lung nodules. However, the suitability of specimens for genetic analysis remains unsatisfa
Externí odkaz:
https://doaj.org/article/a2c13dc2ba6649e2a9221fce980caed2
Autor:
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, Kentaro Ito, Atsushi Fujiwara, Hisamichi Yuda, Hidetoshi Itani, Masahiro Naito, Shuji Kodama, Kazuki Furuhashi, Akihiko Yagi, Haruko Saiki, Taro Yasuma, Tomohito Okano, Atsushi Tomaru, Motoaki Tanigawa, Masamichi Yoshida, Osamu Hataji, Hidenori Ibata, Corina N. D'Alessandro‐Gabazza, Esteban C. Gabazza, Tetsu Kobayashi
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Immune checkpoint inhibitors have recently become the standard of care in the first‐line treatment of extensive‐stage small cell lung cancer. Although immune‐related adverse events have been reported to influence prognosis i
Externí odkaz:
https://doaj.org/article/9d71cbd6a1434c5a9a3174265afbb05d
Autor:
Tadashi Nishimura, Takumi Fujiwara, Hajime Fujimoto, Hirotoshi Tarumi, Chikashi Tsuji, Soichi Iwanaka, Yasumasa Sakakura, Masahiro Naito, Yoshinaga Okugawa, Taro Yasuma, Esteban Cesar Gabazza, Yasuhiro Oomoto, Tetsu Kobayashi, Hidenori Ibata
Publikováno v:
Thoracic Cancer, Vol 14, Iss 7, Pp 709-713 (2023)
Abstract Epidermal growth factor receptor (EGFR)‐mutated squamous cell carcinoma (SCC) is less common than adenocarcinoma. The third‐generation EGFR‐tyrosine kinase inhibitor, osimertinib, is effective in EGFR‐mutated lung adenocarcinoma, but
Externí odkaz:
https://doaj.org/article/9ea80970dd944d21ac84afcf94028e19
Autor:
Yutaka Toyomasu, Kenta Matsui, Kazuki Omori, Akinori Takada, Kyoko Imanaka‐Yoshida, Isao Tawara, Akira Shimamoto, Motoshi Takao, Hiroyasu Kobayashi, Atsushi Tomaru, Hajime Fujimoto, Tetsu Kobayashi, Haiime Sakuma, Yoshihito Nomoto
Publikováno v:
Thoracic Cancer, Vol 13, Iss 20, Pp 2904-2907 (2022)
Abstract Radiation‐induced lung damage (RILD) is a critical problem in lung cancer radiotherapy, and it is difficult to predict its severity. Although no biomarkers for RILD have been established, tenascin C (TNC) is an extracellular matrix glycopr
Externí odkaz:
https://doaj.org/article/7ecba493802b4aa09259857a7537e90a
Autor:
Corina N. D’Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, Masaaki Toda, Ahmed M. Abdel-Hamid, Hajime Fujimoto, Osamu Hataji, Hiroki Nakahara, Atsuro Takeshita, Kota Nishihama, Tomohito Okano, Haruko Saiki, Yuko Okano, Atsushi Tomaru, Valeria Fridman D’Alessandro, Miyako Shiraishi, Akira Mizoguchi, Ryoichi Ono, Junpei Ohtsuka, Masayuki Fukumura, Tetsuya Nosaka, Xuenan Mi, Diwakar Shukla, Kensuke Kataoka, Yasuhiro Kondoh, Masaki Hirose, Toru Arai, Yoshikazu Inoue, Yutaka Yano, Roderick I. Mackie, Isaac Cann, Esteban C. Gabazza
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-23 (2022)
Here, the authors show that treatment with a monoclonal neutralizing antibody against the lung microbiota-derived proapoptotic peptide corisin ameliorates acute exacerbation of pulmonary fibrosis and severity of endotoxin-induced acute lung injury in
Externí odkaz:
https://doaj.org/article/c55325ad1d4042ecbf6c24f945542d94
Autor:
Masamitsu Sugie, Kazumasa Harada, Tetsuya Takahashi, Marina Nara, Hajime Fujimoto, Shunei Kyo, Hideki Ito
Publikováno v:
JCSM Rapid Communications, Vol 4, Iss 2, Pp 141-149 (2021)
Abstract Background Peak oxygen uptake (peak VO2) is known not only as an index of aerobic fitness but also one of an index of life expectancy. Frailty, sarcopenia, and cachexia are associated with a poor prognosis and high mortality. The purpose of
Externí odkaz:
https://doaj.org/article/ba889d5e88d3454b9756b1aca9976ef8